Zhu P - Search Results

1

Novel Insight of Transcription Factor PtrA on Pathogenicity and Carbapenems Resistance in Pseudomonas aeruginosa.

Zhang Y, Wang L, Chen L, Zhu P, Huang N, Chen T, Chen L, Wang Z, Liao W, Cao J, Zhou T. Zhang Y, et al. Among authors: zhu p. Infect Drug Resist. 2022 Aug 4;15:4213-4227. doi: 10.2147/IDR.S371597. eCollection 2022. Infect Drug Resist. 2022. PMID: 35959145 Free PMC article.

2

[A gene related to inhibition of sperm mobility in Staphylococcus aureus from the sperm of infertile men].

Zhu PW, Li JH, Li B, Sun Y, Lin C, Zhou TL. Zhu PW, et al. Zhonghua Nan Ke Xue. 2020 Jul;26(7):605-610. Zhonghua Nan Ke Xue. 2020. PMID: 33377715 Chinese.

3

Detection and Analysis of Wnt Pathway Related lncRNAs Expression Profile in Lung Adenocarcinoma.

Chen J, Hu L, Chen J, Pan Q, Ding H, Xu G, Zhu P, Wen X, Huang K, Wang Y. Chen J, et al. Among authors: zhu p. Pathol Oncol Res. 2016 Jul;22(3):609-15. doi: 10.1007/s12253-016-0046-9. Epub 2016 Feb 9. Pathol Oncol Res. 2016. PMID: 26857641 Free article.

4

Low expression lncRNA RPLP0P2 is associated with poor prognosis and decreased cell proliferation and adhesion ability in lung adenocarcinoma.

Chen J, Hu L, Chen J, Wu F, Hu D, Xu G, Zhu P, Wang Y. Chen J, et al. Among authors: zhu p. Oncol Rep. 2016 Sep;36(3):1665-71. doi: 10.3892/or.2016.4965. Epub 2016 Jul 22. Oncol Rep. 2016. PMID: 27460542

5

J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD.

Chen SD, Zhang H, Rios RS, Li YY, Zhu PW, Jin Y, Ma HL, Tang LJ, Li G, Huang OY, Zheng KI, Byrne CD, Targher G, Zheng MH. Chen SD, et al. Nutr Metab Cardiovasc Dis. 2022 May;32(5):1259-1265. doi: 10.1016/j.numecd.2022.01.035. Epub 2022 Feb 8. Nutr Metab Cardiovasc Dis. 2022. PMID: 35260312

6

Clinical utility of the MAFLD definition.

Zheng KI, Sun DQ, Jin Y, Zhu PW, Zheng MH. Zheng KI, et al. J Hepatol. 2021 Apr;74(4):989-991. doi: 10.1016/j.jhep.2020.12.016. Epub 2020 Dec 24. J Hepatol. 2021. PMID: 33347953 No abstract available.

7

Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case-control study.

Zhang H, Zheng KI, Zhu PW, Chen SD, Li G, Ma HL, Tang LJ, Huang OY, Byrne CD, Targher G, Wang XD, Zheng MH. Zhang H, et al. Eur J Gastroenterol Hepatol. 2022 Aug 1;34(8):838-843. doi: 10.1097/MEG.0000000000002392. Epub 2022 May 27. Eur J Gastroenterol Hepatol. 2022. PMID: 35694803

8

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.

Zhu Q, Li H, Ao Z, Xu H, Luo J, Kaurich C, Yang R, Zhu PW, Chen SD, Wang XD, Tang LJ, Li G, Huang OY, Zheng MH, Li HP, Liu F. Zhu Q, et al. J Nanobiotechnology. 2022 Jul 27;20(1):349. doi: 10.1186/s12951-022-01540-4. J Nanobiotechnology. 2022. PMID: 35897102 Free PMC article.

9

N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD.

Tang LJ, Li G, Eslam M, Zhu PW, Chen SD, Leung HH, Huang OY, Wong GL, Zhou YJ, Karsdal M, Leeming DJ, Jiang P, Wang C, Yuan HY, Byrne CD, Targher G, George J, Wong VW, Zheng MH. Tang LJ, et al. Among authors: zhu pw. Hepatol Int. 2023 Feb;17(1):190-201. doi: 10.1007/s12072-022-10420-w. Epub 2022 Sep 24. Hepatol Int. 2023. PMID: 36152131

10

Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD.

Qiao ZP, Zheng KI, Zhu PW, Gao F, Ma HL, Li G, Li YY, Targher G, Byrne CD, Zheng MH. Qiao ZP, et al. Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1820-1825. doi: 10.1016/j.numecd.2020.05.017. Epub 2020 Jun 2. Nutr Metab Cardiovasc Dis. 2020. PMID: 32636124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,417 results

Search Page